SCHEMBL31542065

SCHEMBL31542065

CCn1c(Cc2ccc(C(=O)NO)cc2)nc2ccc(F)cc2c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 16/20 0.59
HDAC1 Q13547 12/20 0.59
HDAC8 Q9BY41 11/20 0.59
HDAC11 Q96DB2 8/20 0.59
HDAC2 Q92769 5/20 0.59
HDAC3 O15379 3/20 0.53
HDAC4 P56524 3/20 0.53
HDAC7 Q8WUI4 3/20 0.53
HDAC9 Q9UKV0 3/20 0.53
HDAC5 Q9UQL6 3/20 0.53
HDAC10 Q969S8 2/20 0.53
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KCNH2 Q12809 1/20 0.46
ACHE P22303 1/20 0.45
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.44
AGTR1 P30556 1/20 0.42
AGTR2 P50052 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31542079 0.88 PLA2G2A (0.49) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL31542053 0.87 HDAC6 (0.56) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL31542070 0.85 HDAC6 (0.62) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL31542051 0.74 HDAC6 (0.66) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL15301473 0.74 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL23240776 0.73 PDE4A (0.53) LMNAAGTR1AGTR2
SCHEMBL31542056 0.72 HDAC6 (0.53) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL31542057 0.71 HDAC6 (0.60) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL31542075 0.71 HDAC6 (0.53) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL31542062 0.69 HDAC6 (0.58) HDAC6HDAC1HDAC8HDAC11HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP claimed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO claimed
EP-4622964-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION Gilva Therapeutics Co., Ltd. (TW) 2025-10-01 EP disclosed
WO-2025085669-A1 QUINAZOLINONE DERIVATIVES FOR HDAC INHIBITION GILVA THERAPEUTICS CO., LTD. (CN) 2025-04-24 WO disclosed